Home › Funds › Ikarian Capital, LLC › MRNA

Ikarian Capital, LLC position in MRNA

MODERNA INC · Health Care

Ikarian Capital, LLC reported holding 400,000 shares of MRNA (MODERNA INC) in its Q2 2026 13F filing — a position valued at US$28.0M, representing 4.50% of its reported portfolio and ranking #3 among its reported holdings. Ikarian Capital, LLC has disclosed MRNA holdings in 4 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)400.00K sh
Reported value held$28.01M
Portfolio Weight4.50%
First reportedQ3 2023
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Ikarian Capital, LLC's MRNA position evolved

Ikarian Capital, LLC first disclosed a stake in MRNA in Q3 2023 at 2,443 shares (US$25.2M). The position peaked in Q2 2026 at 400,000 shares, worth US$28.0M. Across 4 filings, Ikarian Capital, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 400,000 shares valued at US$28.0M. Notable position changes include a 905% increase in Q4 2023 (shares rose 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.44K $25.23M New
Q4 2023 24.55K $2.44M Add
Q4 2024 100.00K $4.16M New
Q2 2026 400.00K $28.01M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRNA and 13F data

MRNA (MODERNA INC) is a Health Care company. 37 other funds we track also report a position in MRNA — the largest reported positions include Baillie Gifford & Co (US$1.28B), Theleme Partners LLP (US$564.3M), BANQUE PICTET & CIE SA (US$414.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRNA

All MRNA fund holders →

FAQ

How long has Ikarian Capital, LLC held MRNA?

Ikarian Capital, LLC has disclosed MRNA holdings in 4 of the last 12 reported quarters, going back to Q3 2023.

What is Ikarian Capital, LLC's current position in MRNA?

As of Q2 2026, Ikarian Capital, LLC holds 400.00K shares of MRNA (MODERNA INC), valued at $28.01M, representing 4.50% of its reported portfolio and ranking #3.

Has Ikarian Capital, LLC been buying or selling MRNA?

In the latest 13F filing (Q2 2026), Ikarian Capital, LLC newly opened its position in MRNA. The position peaked in Q2 2026 at 400.00K shares.

Which other funds hold MRNA?

Other major institutional holders of MRNA include Baillie Gifford & Co, Theleme Partners LLP, BANQUE PICTET & CIE SA, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.